OTCMKTS:QTXBQuantrx Biomedical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Quantrx Biomedical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.0046 0.00 (0.00 %) (As of 07/10/2020 04:00 PM ET) Add Compare Share Today's Range$0.00Now: $0.00▼$0.0050-Day Range N/A52-Week Range$0.00Now: $0.00▼$0.01Volume21,000 shsAverage Volume190,154 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABeta0.57 ProfileAdvanced ChartCompetitorsEarningsHeadlinesSocial Media QuantRx Biomedical Corporation engages in the development and commercialization patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market, based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infections, urinary incontinences, general catamenial uses, and other medical needs. It also provides InSync, a feminine hygienic interlabial padand; Unique miniform, which is available as a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad, for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. The company was incorporated in 1986 and is based in Tualatin, Oregon.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Quantrx Biomedical. Previous Next 2.1 Community Rank Outperform VotesQuantrx Biomedical has received 48 “outperform” votes. (Add your “outperform” vote.)Underperform VotesQuantrx Biomedical has received 66 “underperform” votes. (Add your “underperform” vote.)Community SentimentQuantrx Biomedical has received 57.89% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Quantrx Biomedical and other stocks. Vote “Outperform” if you believe QTXB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe QTXB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldQuantrx Biomedical does not currently pay a dividend.Dividend GrowthQuantrx Biomedical does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Quantrx Biomedical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 21.90% of the stock of Quantrx Biomedical is held by insiders. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.42 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:QTXB Previous Symbol CUSIPN/A CIKN/A Webwww.quantrx.com Phone212-980-2235Debt Debt-to-Equity RatioN/A Current Ratio0.05 Quick Ratio0.05Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / Book-0.23Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-620,000.00 Net MarginsN/A Return on EquityN/A Return on Assets-206.63%Miscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:QTXB Rates by TradingView Receive QTXB News and Ratings via Email Sign-up to receive the latest news and ratings for QTXB and its competitors with MarketBeat's FREE daily newsletter. Quantrx Biomedical (OTCMKTS:QTXB) Frequently Asked Questions How has Quantrx Biomedical's stock been impacted by COVID-19 (Coronavirus)? Quantrx Biomedical's stock was trading at $0.0046 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, QTXB shares have increased by 0.0% and is now trading at $0.0046. View which stocks have been most impacted by Coronavirus. Has Quantrx Biomedical been receiving favorable news coverage? Headlines about QTXB stock have trended negative on Friday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Quantrx Biomedical earned a media sentiment score of -2.4 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near term. View the latest news about Quantrx Biomedical. Who are some of Quantrx Biomedical's key competitors? Some companies that are related to Quantrx Biomedical include Lombard Medical (EVARF), Oncologix Tech (OCLG), Prourocare Medical (PUMD), Revolutions Medical (RMCP), Scivanta Medical (SCVM), United American Healthcare (UAHC) and Viatar CTC Solutions (VRTT). View all competitors. What other stocks do shareholders of Quantrx Biomedical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Quantrx Biomedical investors own include Consorcio Ara SAB de CV (CNRFF), Auxly Cannabis Group (CBWTF), Christopher & Banks (CBK), Babcock & Wilcox Enterprises (BW), Ascent Solar Technologies (ASTI), Arch Therapeutics (ARTH), Amerigo Resources (ARREF), Blue Apron (APRN), Africa Oil (AOIFF) and Asanko Gold (AKG). Who are Quantrx Biomedical's key executives? Quantrx Biomedical's management team includes the following people: Dr. Shalom Z. Hirschman, Chairman, CEO & Principal Accounting Officer (Age 83) What is Quantrx Biomedical's stock symbol? Quantrx Biomedical trades on the OTCMKTS under the ticker symbol "QTXB." How do I buy shares of Quantrx Biomedical? Shares of QTXB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Quantrx Biomedical's stock price today? One share of QTXB stock can currently be purchased for approximately $0.00. What is Quantrx Biomedical's official website? The official website for Quantrx Biomedical is www.quantrx.com. How can I contact Quantrx Biomedical? Quantrx Biomedical's mailing address is 10190 SW 90TH AVENUE, TUALATIN OR, 97062. The company can be reached via phone at 212-980-2235. This page was last updated on 7/10/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
